Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 49 - Preparations for testing in vivo
Patents for A61K 49 - Preparations for testing in vivo (35,376)
03/1998
03/26/1998WO1998012221A1 Peptide as diagnostic and therapeutic agent for autoimmune diseases
03/26/1998WO1998011922A2 Method
03/26/1998WO1998011921A2 Method
03/26/1998WO1997044067A3 Use of hollow microcapsules
03/26/1998CA2265856A1 Method
03/25/1998CN1177401A Process and compound for use in detecting analytes by measurement of residual magnetism, and the use of said compound
03/25/1998CN1177357A Bismuth compound
03/24/1998US5731351 Antiarrhythmia agents
03/24/1998US5731195 Specified amino acid sequences
03/24/1998US5730956 DTPA di-alkyl monoamides for x-ray and MRI
03/24/1998US5730955 Process for making gas-filled microspheres containing a liquid hydrophobic barrier
03/24/1998US5730954 Preparation comprising cavitate- or clathrate-forming host/guest complexes as contrast agent
03/24/1998US5730953 Radiographic contrast medium
03/19/1998WO1998010800A2 Labelled elastase inhibitors
03/19/1998WO1998010799A1 Improved methods for diagnostic imaging involving the use of a contrast agent and a coronary vasodilator
03/19/1998WO1998010798A1 Improved methods for diagnostic imaging using a contrast agent and a vasodilator
03/19/1998WO1998010797A2 Marker compositions
03/19/1998CA2265945A1 Labelled elastase inhibitors
03/18/1998EP0828520A1 Methods of screening compounds useful for prevention of infection or pathogenicity
03/18/1998EP0828518A1 Gene transfer for treating a connective tissue of a mammalian host
03/18/1998EP0662004B1 Use of persistent free-radicals in magnetic resonance imaging
03/18/1998EP0624097B1 Targeting radioactive immunoreagents
03/18/1998EP0509026B1 Use of an anticoagulant as a diagnostic agent
03/17/1998US5728874 Anti-HIV achiral polyurea oligomers, a process for creating them, formulations using them, and their use in the treatment of AIDS
03/17/1998US5728802 Polypeptides for adhesion of leukocytes
03/17/1998US5728731 Administering a polyamide oligomer to a patient to treat a herpes viral infection
03/17/1998US5728370 Long half-life for magnetic resonance imaging
03/17/1998CA1339737C Fibrin-specific and fibrinogen-specific monoclonal antibodies and their derivation from immunized germ free mice
03/12/1998WO1998010057A1 Methods for testing compounds for use as therapeutic antioxidants
03/12/1998WO1998009600A2 Novel silicon amphiphilic compounds and the use thereof
03/12/1998WO1997046264A3 Pressure resistant protein microspheres as ultrasonic imaging agents
03/12/1998WO1997046262A3 Membrane incorporation of texaphyrins
03/11/1998EP0827511A1 Agents for binding to advanced glycosylation endproducts, and methods of their use
03/11/1998EP0827412A1 Peptide radiopharmaceutical applications
03/11/1998EP0696919A4 Diagnosis and treatment of erectile dysfunction
03/11/1998CN1176001A Process and compound for magnetorelaxometric detection of analytes and use thereof
03/10/1998US5726304 Porphocyanine and CNC-expanded porphyrins
03/10/1998US5726169 Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them
03/10/1998US5726153 Synthetic peptides for arterial imaging
03/10/1998US5726036 Granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof
03/10/1998US5725840 Steroidal ester contrast media for x-ray and magnetic resonance imaging
03/10/1998US5725839 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules for ERI or MRI
03/05/1998WO1998009155A1 Method for detecting cancer on skin of humans and mammals and arrangement for performing the method
03/05/1998WO1998008899A1 Polysaccharide derivative/magnetic metal oxide composite
03/05/1998WO1998008805A1 Process for the preparation of contrast agents
03/05/1998WO1998008747A1 Container containing contrast agents
03/05/1998WO1998003205A3 Enhanced ultrasound contrast imaging using inhaled gases
03/05/1998WO1997033625A3 Water-soluble lipophilic contrast agents
03/05/1998CA2263426A1 Process for the preparation of contrast agents
03/05/1998CA2263125A1 Method for detecting cancer on skin of humans and mammals and arrangement for performing the method
03/04/1998EP0826377A1 Diagnostic agent for diabetes
03/04/1998EP0825996A1 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use
03/04/1998EP0825879A1 Process for the depyrogenation of injectable pharmaceutical solutions
03/04/1998EP0825878A1 Composition and method for tumor imaging
03/04/1998EP0825851A1 Emulsion suitable for administering a poorly water-soluble photosensitizing compound and use thereof
03/04/1998EP0777706B1 High purity ferromagnetic iron oxide pigments
03/04/1998EP0656121B1 Method for diagnosing and monitoring sepsis
03/04/1998CN1175214A Petide P227 analogs, and pharmaceutical compositions comprising them for treatment or diagnosis of diabetes
03/04/1998CN1175208A Cross-linked microparticles and their use as therapeutic vehicles
03/04/1998CN1174742A Complex cow's milk gamma globulin and the making method thereof
03/03/1998US5723719 Transgenic mouse as model for diseases involving dopaminergic dysfunction
03/03/1998US5723104 Monocyclic functional dyes for contrast enhancement in optical imaging
03/03/1998US5722397 Enhancement of transdermal monitoring applications with ultrasound and chemical enhancers
02/1998
02/26/1998WO1998007881A1 T1 receptor-like ligand i
02/26/1998WO1998007732A1 Bismuth dendrimers, processes for their preparation, and their use as x-ray contrast agents
02/26/1998WO1998007730A1 Tin dendrimers, their use as x-ray contrast agents and processes for their preparation
02/26/1998WO1998007414A1 Compositions comprising microparticles of water-insoluble substances and method for preparing same
02/26/1998WO1998007410A1 Methods for the production of protein particles useful for delivery of pharmacological agents
02/26/1998WO1997036617A3 Method of t1-weighted magnetic resonance imaging of res organs
02/26/1998CA2263830A1 T1 receptor-like ligand i
02/26/1998CA2263738A1 Tin dendrimers, their use as x-ray contrast agents and processes for their preparation
02/26/1998CA2263641A1 Bismuth dendrimers, processes for their preparation, and their use as x-ray contrast agents
02/25/1998CN1174511A In-vivo diagnostic process by near infrared radiation
02/25/1998CN1174510A 造影剂 Contrast agent
02/24/1998US5721265 Fluorinated 2-nitroimidazole analogs for detecting hypoxic tumor cells
02/24/1998US5721106 Detecting amount of labelled peptide bound to silk; useful in detecting or monitoring alzheimer's disease
02/24/1998US5720950 Polymers containing antifibrotic agents, compositions containing such polymers, and methods of preparation and use
02/24/1998US5720939 Parenterally administering composite particles comprising a biotolerable, carbohydrate or carbohydrate derivative matrix material
02/24/1998US5720938 Chamber containing void-containing structures, fluorocarbon gas osmotic agent, second chamber containing aqueous liquid, surfactant, seal separating first and second chambers; ultrasound contrast agent
02/19/1998WO1998006442A1 Isotopic urea tablets
02/19/1998WO1998006346A1 Apparatus and method for marking tissue
02/19/1998DE19726340A1 Organo:tin compounds and dendrimeric derivatives
02/19/1998CA2234245A1 Tablet of isotope-labeled urea
02/18/1998EP0823894A1 Azocompounds for the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition
02/18/1998EP0823852A1 Method and prepackaged swab stick for epithelial cancer screening
02/17/1998US5718884 Microbubble-based contrast agents with crosslinked and reduced proteinaceous shells
02/17/1998US5718882 IKVAV peptide radiopharmaceutical applications
02/17/1998US5718388 Continuously feeding therapeutical or imaging agents and rigid grinding media to a milling chamber, contacting the agent with grinding media to reduce particle size, continuously removing and separating
02/12/1998WO1998005626A1 Diagnostic imaging contrast agent with improved in-serum-relaxivity
02/12/1998WO1998005625A1 Diagnostic imaging contrast agent with improved in-serum-relaxivity
02/12/1998WO1998005430A1 Process and device for separating magnetic materials from pharmaceutical compositions, their starting or intermediate products and agents produced by means of this device
02/12/1998WO1998005364A2 Improvements in or relating to contrast agents
02/12/1998WO1998000560A3 Method for determining lymphocyte distribution and trafficking in mammals using imaging
02/12/1998CA2262908A1 Contrast agents for ultrasound imaging of the liver
02/11/1998EP0823438A2 Human mucin cone protein: peptide fragments and antibodies thereto, and uses thereof in diagnostic and therapeutic methods
02/11/1998EP0822837A2 Water soluble fluorinated fatty acid sulfonate derivatives useful as magnetic resonance imaging agents
02/11/1998EP0822836A1 Process for producing polymer microparticles, microparticles produced using said process, and the use of such particles in medical diagnostics
02/11/1998EP0822835A1 Hybrid magnetic resonance contrast agents
02/11/1998EP0714407B1 Composition and methods using nitroxides to avoid oxygen toxicity
02/10/1998US5717121 Preparation and use of contrast agents
1 ... 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 ... 354